Home/Filings/4/0001127602-23-008749
4//SEC Filing

Jonas Daniel S 4

Accession 0001127602-23-008749

CIK 0000816956other

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 4:45 PM ET

Size

21.3 KB

Accession

0001127602-23-008749

Insider Transaction Report

Form 4
Period: 2023-03-01
JONAS DANIEL
VP Legal Affairs, Gen. Counsel
Transactions
  • Exercise/Conversion

    Common Stock

    2023-03-01+2,50014,784 total
  • Exercise/Conversion

    Common Stock

    2023-03-02$59.96/sh+5,400$323,78419,448 total
  • Exercise/Conversion

    Common Stock

    2023-03-02$78.76/sh+5,000$393,80019,048 total
  • Exercise/Conversion

    Rsus (restricted Stock Units)

    2023-03-012,5000 total
    Exercise: $0.00Exp: 2032-03-01Common Stock (2,500 underlying)
  • Award

    Rsus (restricted Stock Units)

    2023-03-01+3,0003,000 total
    Exercise: $0.00Exp: 2033-03-01Common Stock (3,000 underlying)
  • Exercise/Conversion

    Options To Purchase Common Stock

    2023-03-025,4000 total
    Exercise: $59.96Exp: 2028-03-01Common Stock (5,400 underlying)
  • Exercise/Conversion

    Options To Purchase Common Stock

    2023-03-025,0005,000 total
    Exercise: $78.76Exp: 2029-03-01Common Stock (5,000 underlying)
  • Sale

    Common Stock

    2023-03-02$96.25/sh5,400$519,72314,048 total
  • Tax Payment

    Common Stock

    2023-03-01$96.16/sh736$70,77414,048 total
  • Sale

    Common Stock

    2023-03-02$96.08/sh5,000$480,38114,048 total
Footnotes (5)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.03 to $96.24. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
  • [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting 100% after a one year period.
  • [F3]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2018 Long-Term Incentive Plan, with the RSUs vesting in equal amounts (1000 units) over a three year period.
  • [F4]The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.
  • [F5]The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period

Issuer

CONMED Corp

CIK 0000816956

Entity typeother

Related Parties

1
  • filerCIK 0001238334

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 4:45 PM ET
Size
21.3 KB